Guides series, Life Stages and T1D

The Menstrual Cycle and Type 1 Diabetes

A three-part guide for women living with T1D, written for the cycle question that has lived too long on the edge of routine clinic. Part 1 walks the body through the four phases. Part 2 covers what the AID systems can and cannot adjust for. Part 3 widens to contraception, polycystic ovary syndrome, pregnancy, and menopause.

Adult T1D Female life course Evidence-graded

Why this guide exists

In the DAFNE and BERTIE courses, the cycle question keeps coming back. Women describe a pattern they recognise before they check the calendar: three weeks when things mostly behave, then a week when the same meal pulls a glucose curve they have not seen for the previous twenty days. For decades the literature could not match that recognition with the right size of evidence; in the last four years it has caught up. This guide is the bridge between what the women already know and what the data now anchors. The first-person experience of the cycle is yours; the synthesis is mine to bring, with a parent’s eye on the wider T1D arc this connects to.

For decades the cycle question lived on the edge of the T1D literature: small studies in cohorts of six, twelve, fifteen, with the right intuition and the wrong sample size to land an answer. The clinic conversation reflected the literature; the team listened, wrote “investigate” in the notes, and moved on. None of that was carelessness. The evidence simply was not there.

It is now. In the last four years, real-world flash CGM cohorts of hundreds of women, AID-era secondary analyses, and a PRISMA-compliant systematic review have arrived together. The pattern is clear at the population level: forty to sixty per cent of women with T1D notice a measurable cycle-driven glucose change, the luteal phase is where most of the signal lives, AID systems shift the work without erasing it, and the wider hormonal life course (contraception, PCOS, pregnancy, menopause) intersects with T1D at every station. Individual variation is real, and the population pattern does not predict any one woman’s; the data tells you whether the pattern is signal in your own cycles when you overlay it.

This guide brings the evidence together for women living with T1D, the partners and family supporting them, and the clinicians who want a contemporary read. The voice is direct; the evidence is anchored to the named studies; the language is built for taking to the diabetes care team and the wider clinicians who handle each life-course station.

How to read this guide

Each part stands on its own and links back to the others. Read in order if you are new to the topic; jump to the part that fits your question if you already know the cycle pattern in your own data.

Part 1: What the body is doing

The four phases of the cycle, the glucose pattern in each, the heterogeneity of who sees the cycle clearly and who does not, and the conversation script for taking your data to the diabetes care team. Anchored to Tatulashvili 2022, Brown SA 2015, Gamarra and Trimboli 2023 SR, and the GNL Syno cycle dataset.

Open Part 1

Part 2: AID systems across the cycle

What CamAPS FX, Tandem Control-IQ, MiniMed 780G, and Omnipod 5 have been measured to do across the cycle, the AID Algorithm Optimiser ladder reviewed by the manufacturer global medical leads, and the named-system conversation with your diabetes care team. Anchored to Levy 2022, Monroy 2025, Mesa 2024, and the AiDAPT trial cross-link.

Open Part 2

Part 3: Contraception, PCOS, Pregnancy, Menopause

The four hormonal life-course stations where T1D and the wider arc meet most directly. Hormonal versus non-hormonal contraception (Visser 2013 Cochrane); PCOS prevalence and screening in T1DM (Codner 2007, Teede 2023); pregnancy planning, antenatal care, and intrapartum management (NICE NG3, JBDS-IP 12, NPID Audit 2023, CONCEPTT, AiDAPT, HAPO); menopause and T1D, the most under-served station (Courtney 2025, Slopien 2018 EMAS).

Open Part 3

Who this is for, and what it is not

This guide is for adult women living with T1D, the partners and family supporting them, and the clinicians who want a contemporary read. The age scope is adult and older-adult; the menarche transition for T1D girls is covered in the Paediatric T1D guide, and adolescent cycle physiology will be added there as the paediatric pack opens its menarche-transition section.

This guide is educational. It explains population-average patterns and gives you the language to ask. It does not give doses, it does not personalise correction, and it is not a substitute for the conversation with your diabetes care team. The numbers your team gives you, on your data, in your context, are the ones that count.

The Glucose Never Lies. The body talks back honestly through the glucose; the cycle is one of the rhythms it talks in. This guide translates the rhythm with recognition, not as a results table.

Connected GNL resources

The cycle conversation lives next to several other GNL areas. The cross-links here are the practical entry points.

  • Hypoglycaemia and the Hypo Treatment explorer. For ovulatory-window or pregnancy-phase hypoglycaemia management.
  • AID systems guide. For the four UK AID systems in depth, beyond the cycle-specific lens used in Part 2.
  • Exercise and T1D guide. For sex-difference exercise glucose responses (Yardley 2024 T1DEXI), an open evidence area at the cycle-exercise interaction.
  • Paediatric T1D guide. For the menarche transition for T1D girls, where the adult cycle conversation begins.
  • Ask Grace. The free GNL clinical AI, opened to all registered audiences, draws from the same evidence base; ask any cycle question for a Grace-voiced read with citations.

Evidence backbone, the whole guide

The site delivery is voice-first; the underlying evidence layer is research-grade and lives in the GNL Grace wiki. The two are kept separate by design: the wiki feeds Grace’s RAG, the guide feeds the reader.

  • Concept page (data backbone Grace draws from): gnl-grace/wiki/concepts/menstrual-cycle-and-t1d.md, twenty-three linked sources across seven sub-topic groups, source_count 23.
  • Evidence grade map (per-source and per-claim): gnl-grace/wiki/evidence-grades/menstrual-evidence.md, overall Grade B, twenty-two per-source rows, thirteen per-claim rows, seven residual gaps catalogued.
  • Pack programme row: Pack 12 in gnl-grace/PACK_PROGRAMME.md, two same-day library passes (5 May 2026), eighteen new sources linked, residual library queue documented.

If a clinician or researcher wants to dig deeper than the guide, the wiki concept page and grade map are the starting point. If a reader wants to test a specific claim against Grace’s full evidence base, Ask Grace is the route.

Authorship and review

Written by John Pemberton with the GNL editorial team. The hats worn across this guide are: the structured-education clinician (DAFNE, BERTIE, DYNAMIC, GAME), the paediatric DSN at Birmingham Women’s and Children’s NHS Foundation Trust, the researcher and manuscript author, the GNL founder, and, in the Part 3 menopause section, the T1D parent. The first-person experience of the cycle is the reader’s, not the author’s; the synthesis is the author’s to bring. The voice rule this guide follows is locked at docs/GNL_WRITER_SPEC.md and gnl-grace/wiki/policies/gnl-voice-and-storytelling.md (5 May 2026).

If you are a clinician with feedback on the contemporary evidence read, or a woman living with T1D with a cycle pattern that this guide should account for, the contact is john@theglucoseneverlies.com.

Ask Grace